RSS Feeds
Search

Companies

ESBATech

Drug Discovery

The company in detail

Summary

Founded in 1998, ESBATech is a privately owned spin-off biotechnology company that originated from the University of Zurich, Switzerland. ESBATech is focused on developing its therapeutic applications of its proprietary fully human antibody fragments. The company is aiming to become one of the leading companies in human antibody fragments for therapeutic applications.

Partnerships

To view this information, you must subscribe to Pharmalicensing Intelligence.

Deals

To view this information, you must subscribe to Pharmalicensing Intelligence.

Senior management

To view this information, you must subscribe to Pharmalicensing Intelligence.

Board of directors

To view this information, you must subscribe to Pharmalicensing Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us